Search research articles
Contact Us
Filters
Showing results (61-70 of 69) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 69 results.
Lancet (London, England)
|
September 17, 2019
Sustained outcomes in oral immunotherapy for peanut allergy (POISED study): a large, randomised, double-blind, placebo-controlled, phase 2 study
R Sharon Chinthrajah, Natasha Purington, Sandra Andorf, et al.
Frontiers in Immunology
|
October 10, 2018
Eliciting Dose and Safety Outcomes From a Large Dataset of Standardized Multiple Food Challenges
Natasha Purington, R Sharon Chinthrajah, Andrew Long, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)
|
August 12, 2009
Metastasis of uveal melanoma millimeter-by-millimeter in 8033 consecutive eyes
Carol L Shields, Minoru Furuta, Archana Thangappan, et al.
Eclinicalmedicine
|
June 14, 2019
A Phase 2 Randomized Controlled Multisite Study Using Omalizumab-facilitated Rapid Desensitization to Test Continued <i>vs</i> Discontinued Dosing in Multifood Allergic Individuals
Sandra Andorf, Natasha Purington, Divya Kumar, et al.
The Journal of Allergy and Clinical Immunology
|
March 5, 2023
The role of biologics in pediatric food allergy and eosinophilic gastrointestinal disorders
Sayantani B Sindher, Suzanne Barshow, Jyothi Tirumalasetty, et al.
The Journal of Allergy and Clinical Immunology. Global
|
October 2, 2023
Protocol design and synopsis: Omalizumab as Monotherapy and as Adjunct Therapy to Multiallergen OIT in Children and Adults with Food Allergy (OUtMATCH)
Robert A Wood, R Sharon Chinthrajah, Amanda K Rudman Spergel, et al.
The Journal of Allergy and Clinical Immunology
|
November 4, 2019
Conflicting verdicts on peanut oral immunotherapy from the Institute for Clinical and Economic Review and US Food and Drug Administration Advisory Committee: Where do we go from here?
Thomas Eiwegger, Katherine Anagnostou, Stefania Arasi, et al.
The Journal of Allergy and Clinical Immunology
|
May 30, 2025
Introduction of allergenic foods after treatment with omalizumab
Jennifer Dantzer, Yamini Virkud, Julie Wang, et al.
The New England Journal of Medicine
|
February 26, 2024
Omalizumab for the Treatment of Multiple Food Allergies
Robert A Wood, Alkis Togias, Scott H Sicherer, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 69) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 69 results.
Lancet (London, England)
|
September 17, 2019
Sustained outcomes in oral immunotherapy for peanut allergy (POISED study): a large, randomised, double-blind, placebo-controlled, phase 2 study
R Sharon Chinthrajah, Natasha Purington, Sandra Andorf, et al.
Frontiers in Immunology
|
October 10, 2018
Eliciting Dose and Safety Outcomes From a Large Dataset of Standardized Multiple Food Challenges
Natasha Purington, R Sharon Chinthrajah, Andrew Long, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)
|
August 12, 2009
Metastasis of uveal melanoma millimeter-by-millimeter in 8033 consecutive eyes
Carol L Shields, Minoru Furuta, Archana Thangappan, et al.
Eclinicalmedicine
|
June 14, 2019
A Phase 2 Randomized Controlled Multisite Study Using Omalizumab-facilitated Rapid Desensitization to Test Continued <i>vs</i> Discontinued Dosing in Multifood Allergic Individuals
Sandra Andorf, Natasha Purington, Divya Kumar, et al.
The Journal of Allergy and Clinical Immunology
|
March 5, 2023
The role of biologics in pediatric food allergy and eosinophilic gastrointestinal disorders
Sayantani B Sindher, Suzanne Barshow, Jyothi Tirumalasetty, et al.
The Journal of Allergy and Clinical Immunology. Global
|
October 2, 2023
Protocol design and synopsis: Omalizumab as Monotherapy and as Adjunct Therapy to Multiallergen OIT in Children and Adults with Food Allergy (OUtMATCH)
Robert A Wood, R Sharon Chinthrajah, Amanda K Rudman Spergel, et al.
The Journal of Allergy and Clinical Immunology
|
November 4, 2019
Conflicting verdicts on peanut oral immunotherapy from the Institute for Clinical and Economic Review and US Food and Drug Administration Advisory Committee: Where do we go from here?
Thomas Eiwegger, Katherine Anagnostou, Stefania Arasi, et al.
The Journal of Allergy and Clinical Immunology
|
May 30, 2025
Introduction of allergenic foods after treatment with omalizumab
Jennifer Dantzer, Yamini Virkud, Julie Wang, et al.
The New England Journal of Medicine
|
February 26, 2024
Omalizumab for the Treatment of Multiple Food Allergies
Robert A Wood, Alkis Togias, Scott H Sicherer, et al.
Page
of 7